CEN/TS 17626:2021

Molecular in vitro diagnostic examinations - Specifications for pre-examination processes for human specimen - Isolated microbiome DNA CEN/TS 17626:2021

Publication date:   Sep 16, 2021

General information

60.60 Standard published   May 5, 2021

CEN

CEN/TC 140 In vitro diagnostic medical devices

Technical Specification

11.100.01   Laboratory medicine in general

Buying

Published

Language in which you want to receive the document.

Scope

This document specifies requirements and gives recommendations for the pre-examination phase of human specimens, such as stool, saliva, skin and urogenital specimens, intended for microbiome DNA examination. The pre-examination phase includes but is not limited to specimen collection, handling, transport, storage, processing, isolation of DNA, and documentation.
This document is applicable to molecular in vitro diagnostic examinations performed by medical laboratories. It is also intended to be used by laboratory customers, in vitro diagnostics developers and manufacturers, biobanks, institutions and commercial organizations performing biomedical research, and regulatory authorities.
Different dedicated measures are taken for pre-examination processes for infectious disease examination (e.g. targeted pathogen identification) and for microbiome DNA examination from tissue (e.g. biopsies). These are outside of the scope of this document.
Different dedicated measures are taken for pre-examination processes for saliva for human genomic DNA examination. These are not described in this document but are covered in CEN/TS 17305, Molecular in vitro diagnostic examinations - Specifications for pre-examination processes for saliva - Isolated DNA.
NOTE International, national or regional regulations or requirements can also apply to specific topics covered in this document.

Life cycle

NOW

PUBLISHED
CEN/TS 17626:2021
60.60 Standard published
May 5, 2021

REVISED BY

IN_DEVELOPMENT
prCEN ISO/TS 18701